| 151 |
12668898 | Prevention and treatment of reactions to NSAIDs. | 2003 Apr |
1 |
| 152 |
12705064 | Selective COX-2 inhibitors: a health economic perspective. | 2003 |
1 |
| 153 |
12723742 | Relative efficacy of selective COX-2 inhibitors compared with over-the-counter ibuprofen. | 2003 Apr |
1 |
| 154 |
12723745 | Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs. | 2003 Apr |
1 |
| 155 |
12740337 | Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study. | 2003 Jun |
1 |
| 156 |
12749519 | A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population. | 2003 Feb |
1 |
| 157 |
12782016 | The role of COX-2 in angiogenesis and rheumatoid arthritis. | 2003 Jun |
1 |
| 158 |
12783912 | Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. | 2003 Jun 4 |
1 |
| 159 |
12816152 | Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity. | 2003 |
1 |
| 160 |
12818939 | An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. | 2003 Jul |
1 |
| 161 |
12845388 | Effects of renal insufficiency and hemodialysis on the pharmacokinetics of rofecoxib. | 2003 Jul-Aug |
2 |
| 162 |
12859668 | Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. | 2003 Aug |
3 |
| 163 |
12868201 | [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects]. | 2003 Apr |
1 |
| 164 |
12890715 | Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. | 2003 Aug |
1 |
| 165 |
12902855 | COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting. | 2003 Aug |
2 |
| 166 |
12906745 | Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. | 2003 Jul |
1 |
| 167 |
12910695 | [The effects of selective cyclooxygenase-2 inhibitors on the growth of gastric adenocarcinoma]. | 2003 Jul |
1 |
| 168 |
12941996 | Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. | 2003 May 1 |
1 |
| 169 |
12975714 | A retrospective review of the effect of COX-2 inhibitors on blood pressure change. | 2003 Sep-Oct |
1 |
| 170 |
14504873 | A comparative study of the effect of rofecoxib (a COX 2 inhibitor) and naproxen sodium on analgesic requirements after abdominal hysterectomy. | 2003 Oct |
1 |
| 171 |
14524083 | [Selective COX 2 inhibitor rofecoxib. To "defy" the pain]. | 2003 Aug 7 |
1 |
| 172 |
14530224 | Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. | 2003 Oct 7 |
1 |
| 173 |
14552704 | Clinical pharmacology of selective COX-2 inhibitors. | 2003 May-Aug |
1 |
| 174 |
14585914 | Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec. | 2003 Nov |
1 |
| 175 |
14592550 | Obligatory role of lipid mediators in platelet-neutrophil adhesion. | 2003 Jun 15 |
1 |
| 176 |
14627347 | Rofecoxib reduces polyp recurrence in familial polyposis. | 2003 Oct |
1 |
| 177 |
14655004 | [Clinical pharmacology of the selective COX-2 inhibitors]. | 2003 Dec |
1 |
| 178 |
15071803 | High performance liquid chromatographic determination of cox-2 inhibitor rofecoxib in human plasma. | 2003 Aug |
1 |
| 179 |
15199473 | Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. | 2003 May |
2 |
| 180 |
11866383 | A rapid and sensitive high-performance liquid chromatography assay for rofecoxib in human serum. | 2002 Jan |
1 |
| 181 |
11898894 | Gastrointestinal bleeds associated with rofecoxib. | 2002 Mar |
1 |
| 182 |
11909557 | Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. | 2002 Mar 21 |
1 |
| 183 |
11940070 | Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. | 2002 Mar |
1 |
| 184 |
11945113 | Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution. | 2002 |
1 |
| 185 |
11992745 | Renal effects of cyclooxygyenase-2-selective inhibitors. | 2002 Apr |
1 |
| 186 |
12017215 | A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents. | 2002 |
1 |
| 187 |
12065343 | Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. | 2002 Jun |
1 |
| 188 |
12086291 | Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors. | 2002 |
1 |
| 189 |
12100094 | Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. | 2002 May |
1 |
| 190 |
12113843 | Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet. | 2002 May |
1 |
| 191 |
12126328 | What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex). | 2002 Jun 25 |
2 |
| 192 |
12141411 | Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. | 2002 Jul |
1 |
| 193 |
12198983 | Selecting new drugs for pain control: evidence-based decisions or clinical impressions? | 2002 Aug |
1 |
| 194 |
12204486 | The impact of pain management on quality of life. | 2002 Jul |
1 |
| 195 |
12217369 | Isomeric acetoxy analogues of rofecoxib: a novel class of highly potent and selective cyclooxygenase-2 inhibitors. | 2002 Oct 7 |
2 |
| 196 |
12220285 | Rofecoxib-induced instant aquagenic wrinkling of the palms. | 2002 Jul-Aug |
1 |
| 197 |
12389882 | Cyclooxygenase-2 inhibitor-associated acute renal failure: case report with rofecoxib and review of the literature. | 2002 Oct |
1 |
| 198 |
12395741 | [Anti-inflammatory non-steroidal selective cyclooxygenase 2 inhibitors and gastroduodenal lesions]. | 2002 Sep 28 |
1 |
| 199 |
12406411 | [Economic evaluation of a new selective COX-2 NSAID, rofecoxib, in a real practice context]. | 2002 Oct 31 |
1 |
| 200 |
12410658 | Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy. | 2002 Nov |
1 |